GI
XENE icon

GAMMA Investing’s Xenon Pharmaceuticals XENE Stock Holding History

GAMMA Investing’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3K Buy
518
+145
+39% +$8.05K ﹤0.01% 2591
2026
Q1 		$21.7K Buy
373
+109
+41% +$5.02K ﹤0.01% 2672
2025
Q4 		$11.8K Buy
264
+79
+43% +$3.32K ﹤0.01% 2899
2025
Q3 		$7.43K Buy
185
+171
+1,221% +$6.02K ﹤0.01% 3014
2025
Q2 		$438 Buy
14
+6
+75% +$196 ﹤0.01% 3650
2025
Q1 		$268 Sell
8
-43
-84% -$1.63K ﹤0.01% 3741
2024
Q4 		$2K Sell
51
-8
-14% -$331 ﹤0.01% 3223
2024
Q3 		$2.32K Buy
59
+21
+55% +$847 ﹤0.01% 3024
2024
Q2 		$1.48K Buy
38
+3
+9% +$120 ﹤0.01% 2965
2024
Q1 		$1.51K Buy
35
+13
+59% +$598 ﹤0.01% 2839
2023
Q4 		$995 Buy
+22
New +$777 ﹤0.01% 2790

Other funds holding XENE

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
FIA
FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM